Ascentage Pharma Group International (NASDAQ:AAPG - Get Free Report)'s stock price gapped up prior to trading on Thursday . The stock had previously closed at $18.37, but opened at $19.96. Ascentage Pharma Group International shares last traded at $20.05, with a volume of 23,192 shares changing hands.
Wall Street Analysts Forecast Growth
Separately, JPMorgan Chase & Co. began coverage on Ascentage Pharma Group International in a research note on Thursday. They issued an "overweight" rating for the company.
Get Our Latest Report on AAPG
Ascentage Pharma Group International Stock Up 0.2 %
Ascentage Pharma Group International Company Profile
(
Get Free Report)
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Read More
Before you consider Ascentage Pharma Group International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ascentage Pharma Group International wasn't on the list.
While Ascentage Pharma Group International currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
